Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer. - Burris, Howard A.; Chan, Arlene; Bardia, Aditya; Thaddeus Beck, J.; Sohn, Joohyuk; Neven, Patrick; Tripathy, Debu; Im, Seock-Ah; Chia, Stephen; Esteva, Francisco J.; Hart, Lowell; Zarate, Juan Pablo; et al. (British Journal of Cancer, 2021)